EyePoint (EYPT) Other Operating Expenses (2011 - 2026)
EyePoint (EYPT) posted Other Operating Expenses of -$82.4 million for Q1 2026, down 119.96% sequentially from $413.1 million in Q4 2025, and down 775.62% YoY from $12.2 million in Q1 2025.
EyePoint (EYPT) Other Operating Expenses (2011 - 2026) Analysis & Trends
EyePoint has reported Other Operating Expenses for 13 years, with the latest figure at -$82.4 million in Q1 2026.
- Quarterly Other Operating Expenses fell 775.62% year-over-year to -$82.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $272.6 million (up 254.87% YoY) and the FY2025 annual result came in at $223.1 million, up 5705.49% from the prior year.
- Other Operating Expenses eased to -$82.4 million in Q1 2026 per EYPT's latest filing, from $413.1 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $413.1 million in Q4 2025 and troughed at -$88.6 million in Q4 2024.
- A 5-year average of $8.1 million and a median of $765000.0 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2024 and 2025: Other Operating Expenses sank 2421.89% in 2024, then soared 566.19% in 2025.
- Over 5 years, Other Operating Expenses stood at $39.9 million in 2022, then plunged by 222.32% to -$48.8 million in 2023, then sank by 81.74% to -$88.6 million in 2024, then jumped by 566.19% to $413.1 million in 2025, then slumped by 119.96% to -$82.4 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$82.4 million, $413.1 million, and -$58.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31,000.00 |
| Mar 31, 2026 | -82.43 Mn |
| Dec 31, 2025 | 413.08 Mn |
| Sep 30, 2025 | -58.23 Mn |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | -9.41 Mn |
| Dec 31, 2024 | -88.61 Mn |
| Sep 30, 2024 | -39.03 Mn |
| Jun 30, 2024 | -38.98 Mn |
| Mar 31, 2024 | 765,000.00 |
| Dec 31, 2023 | -48.75 Mn |
| Sep 30, 2023 | 1.68 Mn |
| Jun 30, 2023 | 7.08 Mn |
| Mar 31, 2023 | 14.26 Mn |
| Dec 31, 2022 | 39.86 Mn |
| Sep 30, 2022 | 8.04 Mn |
| Jun 30, 2022 | 9.23 Mn |
| Mar 31, 2022 | 9.09 Mn |
| Dec 31, 2021 | 18.78 Mn |
| Sep 30, 2021 | 9.81 Mn |